Valuation Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
17:27:00 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 114.12 USD | +1.17% |
|
+13.14% | +45.58% |
| 08-10 | Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026 | |
| 08-10 | Mesa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Mesa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,337 | 934.1 | 591.9 | 644.8 | 488.5 | 631.2 | - |
| Change | - | -30.14% | -36.64% | 8.93% | -24.23% | 29.21% | - |
| Enterprise Value (EV) | 1,506 | 1,084 | 591.9 | 644.8 | 488.5 | 631.2 | 631.2 |
| Change | - | -27.99% | -45.42% | 8.93% | -24.23% | 29.21% | 0% |
| P/E | 728x | 1,028x | -2.32x | -330x | 73.1x | 53.4x | 39.7x |
| PBR | 3.41x | 2.38x | 4.07x | 4.05x | 2.62x | 3.23x | 2.94x |
| PEG | - | -20x | 0x | 3.3x | -0x | 0.7x | 1.1x |
| Capitalization / Revenue | 7.25x | 4.26x | 2.74x | 2.68x | 1.96x | 2.47x | 2.33x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.47x | 2.33x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.3x | 9.2x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 10.4x | 9.58x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 14.2x | 13.5x |
| FCF Yield | 2.6% | 2.51% | 7.02% | 6.6% | 8.1% | 7.03% | 7.4% |
| Dividend per Share 2 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Rate of return | 0.25% | 0.37% | 0.58% | 0.54% | 0.72% | 0.57% | 0.57% |
| EPS 2 | 0.35 | 0.17 | -47.2 | -0.36 | 1.21 | 2.113 | 2.843 |
| Distribution rate | 183% | 376% | -1.36% | -178% | 52.9% | 30.3% | 22.5% |
| Net sales 1 | 184.3 | 219.1 | 216.2 | 241 | 249.1 | 255.4 | 270.6 |
| EBITDA 1 | 41.16 | 49.68 | 50.5 | 56.74 | 63.49 | 61.4 | 68.6 |
| EBIT 1 | 37.9 | 45.82 | 50.5 | 51.36 | 58.23 | 60.5 | 65.9 |
| Net income 1 | 1.871 | 0.93 | -254.2 | -1.974 | 6.712 | 11.7 | 17.1 |
| Net Debt | 169 | 150.4 | - | - | - | - | - |
| Reference price 2 | 254.88 | 174.73 | 109.73 | 118.66 | 88.42 | 112.80 | 112.80 |
| Nbr of stocks (in thousands) | 5,246 | 5,346 | 5,394 | 5,434 | 5,525 | 5,596 | - |
| Announcement Date | 31/05/22 | 25/05/23 | 05/06/24 | 28/05/25 | 27/05/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 53.38x | - | - | 0.57% | 631M | |
| 31.83x | 4.29x | 16.61x | 2.32% | 192B | |
| 20.57x | 3.56x | 12.52x | 3.28% | 116B | |
| 17.2x | 0.2x | 12.44x | 0.76% | 59.95B | |
| 31.77x | 7.93x | 20.18x | 1.25% | 54.64B | |
| 37.93x | 3.42x | 11.71x | 2.14% | 50B | |
| 36.4x | 6.41x | 20.11x | -.--% | 34.26B | |
| 46.2x | 1.31x | 12.01x | 0.16% | 31.15B | |
| 41.08x | 7.2x | 25.83x | 0.26% | 24.79B | |
| 20.67x | 3.12x | 11.69x | 1.41% | 24.07B | |
| Average | 33.70x | 4.16x | 15.90x | 1.21% | 58.76B | |
| Weighted average by Cap. | 29.61x | 4.03x | 15.44x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MLAB Stock
- Valuation Mesa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
